Enrique Miranda

1.3k total citations
15 papers, 664 citations indexed

About

Enrique Miranda is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Enrique Miranda has authored 15 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Enrique Miranda's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Virus-based gene therapy research (3 papers). Enrique Miranda is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Virus-based gene therapy research (3 papers). Enrique Miranda collaborates with scholars based in United Kingdom, Mexico and Portugal. Enrique Miranda's co-authors include Kerry Chester, Mark E. B. Smith, Vijay Chudasama, Antoine Maruani, Stephen Caddick, James R. Baker, Nicholas R. Lemoine, Gunnel Halldén, Alejandro Garcı́a-Carrancá and Emilio Rojas and has published in prestigious journals such as Nature Communications, PLoS ONE and Chemical Communications.

In The Last Decade

Enrique Miranda

15 papers receiving 652 citations

Peers

Enrique Miranda
RG Melton United Kingdom
Ryan Dorton United States
David Coomber Singapore
Edgar Wawra Austria
Luke A. Masterson United Kingdom
Enrique Miranda
Citations per year, relative to Enrique Miranda Enrique Miranda (= 1×) peers Toshie Iwai

Countries citing papers authored by Enrique Miranda

Since Specialization
Citations

This map shows the geographic impact of Enrique Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enrique Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enrique Miranda more than expected).

Fields of papers citing papers by Enrique Miranda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enrique Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enrique Miranda. The network helps show where Enrique Miranda may publish in the future.

Co-authorship network of co-authors of Enrique Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Enrique Miranda. A scholar is included among the top collaborators of Enrique Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enrique Miranda. Enrique Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Miranda, Enrique, et al.. (2022). A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers. Molecular Therapy — Oncolytics. 26. 429–443. 15 indexed citations
2.
Forte, Nafsika, Enrique Miranda, Maurício Morais, et al.. (2018). Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs. Bioconjugate Chemistry. 29(2). 486–492. 45 indexed citations
3.
Maruani, Antoine, Mark E. B. Smith, Enrique Miranda, et al.. (2015). A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy. Nature Communications. 6(1). 6645–6645. 197 indexed citations
4.
Tolner, Berend, et al.. (2015). IMAC capture of recombinant protein from unclarified mammalian cell feed streams. Biotechnology and Bioengineering. 113(1). 130–140. 13 indexed citations
5.
Goldstein, Robert M., Jane Sosabowski, Julius Leyton, et al.. (2014). Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging. European Journal of Nuclear Medicine and Molecular Imaging. 42(2). 288–301. 74 indexed citations
6.
Miranda, Enrique, et al.. (2014). Homogeneous Bispecifics by Disulfide Bridging. Bioconjugate Chemistry. 25(8). 1395–1401. 50 indexed citations
7.
Maruani, Antoine, Felix Schumacher, Enrique Miranda, et al.. (2013). Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation. Chemical Communications. 49(74). 8187–8187. 61 indexed citations
8.
Kogelberg, Heide, Enrique Miranda, Jerome Burnet, et al.. (2013). Generation and Characterization of a Diabody Targeting the αvβ6 Integrin. PLoS ONE. 8(9). e73260–e73260. 12 indexed citations
10.
Peñafiel, Christian Omar Ramos, et al.. (2011). Tratamiento de la leucemia linfoide aguda del adulto: Experiencia de un hospital en la Ciudad de México. Revista médica de Chile. 139(9). 1135–1142. 8 indexed citations
12.
Sweeney, Katrina, Daniel Öberg, Derek Davies, et al.. (2009). Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clinical Cancer Research. 15(5). 1730–1740. 60 indexed citations
13.
Solano, Sandra, et al.. (2005). The implantation of Taenia solium metacestodes in mice induces down-modulation of T-cell proliferation and cytokine production. Parasitology Research. 95(4). 256–265. 11 indexed citations
14.
Gandolfi, Alberto, et al.. (2001). [Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature].. PubMed. 92(3). 197–9. 4 indexed citations
15.
Salazar, Ana María, et al.. (1997). Induction of p53 protein expression by sodium arsenite. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 381(2). 259–265. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026